In vitro antibacterial activity of some Iranian medicinal plant extracts against Helicobacter pylori

Natural Product Research

Volumn 25, Issue 11, 2011, Pages 1059-1066

  Hajimahmoodi, M ^a   Shams Ardakani, M ^a   Saniee, P ^b   Siavoshi, F ^b   Mehrabani, M ^c   Hosseinzadeh, H ^d   Foroumadi, P ^d   Safavi, M ^d   Khanavi, M ^a   Akbarzadeh, T ^d   Shafiee, A ^d   Foroumadi, A ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Helicobacter pylori; Medicinal plants; Peel extracts; Punica granatum

Indexed keywords

ANTIINFECTIVE AGENT; JUGLANS REGIA EXTRACT; METRONIDAZOLE; PLANT EXTRACT; PUNICA GRANATUM EXTRACT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DISK DIFFUSION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MEDICINAL PLANT; NONHUMAN; POMEGRANATE; STOMACH BIOPSY; WALNUT;

ANTI-BACTERIAL AGENTS; HELICOBACTER PYLORI; PLANT EXTRACTS; PLANTS, MEDICINAL; PUNICACEAE;

HELICOBACTER PYLORI; JUGLANS REGIA; LYTHRACEAE; PUNICA GRANATUM;

EID: 79960511104     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786419.2010.501763     Document Type: Article

References (37)

1. Al-Zoreky, N. S. (2009). Antimicrobial activity of pomegranate (Punica granatum L.) fruit peels. International Journal of Food Microbiology, 134, 244-242.
2. Atapour, M., Zahedi, M. J., Mehrabani, M., Safavi, M., Keyvanfard, V., Foroughi, A., Foroumadi, A. (2009). In vitro susceptibility of the Gram-negative bacterium Helicobacter pylori to extracts of Iranian medicinal plants. Pharmaceutical Biology, 47(1), 77-80.
3. Barimani, L. (1987). Traditional medicine and traditional drugs (1st ed.). Tehran: Gutenberg (in Persian).
4. Buzas, G. M., & Jozan, J. (2007). Nitrofuran-based regimens for the eradication of Helicobacter pylori infection. Journal of Gastroenterology and Hepatology, 22, 1571-1581. (Pubitemid 47383342)
5. Castillo-Juárez, I., Rivero-Cruz, F., Celis, H., & Romero, I. (2007). Anti-Helicobacter pylori activity of anacardic acids from Amphipterygium adstringens. Journal of Ethnopharmacology, 114(1), 72-77. (Pubitemid 47444510)
6. Chi, C. H., Lin, C. Y., Sheu, B. S., Yang, H. B., Huang, A. H., & Wu, J. J. (2003). Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori. Alimentary Pharmacology Therapeutics, 18(3), 347-353.
7. Esmaeili, A., Rustaiyan, A., Nadimi, M., Larijani, K., Nadjafi, F., & Tabrizi, L. (2008). Chemical composition and antibacterial activity of essential oils from leaves, stems and flowers of Salvia reuterana Boiss. grown in Iran. Natural Product Research, 22(6), 516-520. (Pubitemid 351560231)
8. Fadavi, A., Barzegar, M., & Azizi, M. H. (2006). Determination of fatty acids and total lipid content in oilseed of 25 pomegranates varieties grown in Iran. Journal of Food Composition and Analysis, 19, 676-680. (Pubitemid 43840937)
9. Fischbach, L., & Evans, E. L. (2007). Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Alimentary Pharmacology Therapeutics, 26(3), 343-357. (Pubitemid 47063149)
10. Foroumadi, A., Asadipour, A., Arabpour, F., & Amanzadeh, Y. (2002). Composition of the essential oil of Bunium persicum (Bioss.) B. Fedtsch. from Iran. The Journal of Essential Oil Research, 14, 161-162. (Pubitemid 34473601)
11. Foroumadi, A., Safavi, M., Emami, S., Siavoshi, F., Najjari, S., Safari, F., Shafice, A. (2008). Structure-activity relationship study of a series of N-substituted piperazinylfluoroquinolones as anti-Helicobacter pylori agents. Medicinal Chemistry, 4, 498-502.
12. Gisbert, J. P., Castro-Fernandez, M., Bermejo, F., P'erez Aisa, A., Ducons, J., Andezbermejo, M. F., Olivares, D. (2006). Third-line rescue therapy with levofloxacin after two H. pylori treatment failures. The American Journal of Gastroenterology, 101, 243-247. (Pubitemid 43381662)
13. Gisbert, J. P., Gisbert, J. L., Marcos, S., Moreno-Otero, R., & Pajares, J. M. (2007). Levofloxacin-vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure. Helicobacter, 12, 68-73. (Pubitemid 46105922)
14. Gisbert, J. P., & Pajares, J. M. (2001). Helicobacter pylori therapy: first-line options and rescue regimen. Digestive Diseases, 19(2), 134-143. (Pubitemid 32823925)
15. Graham, D. Y., de Boer, W. A., & Tytgat, G. N. (1996). Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance. The American Journal of Gastroenterology, 91, 1072-1076. (Pubitemid 26175462)
16. Graham, D. Y., Lew, G. M., Klein, P. D., Evans, D. G., Evans, D. J., Saeed, Z. A., Malaty, H. M. (1992). Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Annals Internal Medicine, 116, 705-708. (Pubitemid 23033112)
17. Khanavi, M., Safavi, M., Siavoshi, F., Fallah Tafti, A., Hajimahmoodi, M., Hadjiakhoondi, A., Foroumadi, A. (2008). Evaluation of anti-Helicobacter pylori activity of methanol extracts of some species of Stachys and Melia. Journal of Medicinal Plants, 7(28), 74-80.
18. Kwon, D. H., El-Zaatari, F. A. K., Kato, M., Osato, M. S., Reddy, R., Yamaoka, Y., & Graham, D. Y. (2000). Analysis of rdxA and involvement of additional genes encoding NAD (P) H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori. Antimicrobial Agents and Chemotherapy, 44(8), 2133-2142. (Pubitemid 30484438)
19. Lamouliatte, H., Megraud, F., Delchier, J. C., Bretagne, J. F., Courillon-Mallet, A., De Korwin, J. D., Barthelemy, P. (2003). Multicentre study group. Second-line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies. Alimentary Pharmacology Therapeutics, 15, 18(8), 791-797. (Pubitemid 37323644)
20. Li, Y., Xu, C., Zhang, Q., Liu, J. Y., & Tan, R. X. (2005). In vitro anti-Helicobacter pylori action of 30 Chinese herbal medicines used to treat ulcer disease. Journal of Ethnopharmacology, 98, 329-333. (Pubitemid 40461989)
21. Malekzadeh, F., Ehsanifar, H., Shahamat, M., Levin, M., & Colwell, R. R. (2001). Antibacterial activity of black myrobalan Terminalia chebula Retz against Helicobacter pylori. International Journal of Antimicrobial Agents, 18, 85-88. (Pubitemid 32703873)
22. Marshall, B. J., & Warren, J. R. (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet, 16, 1311-1315.
23. Nariman, F., Eftekhar, F., Habibi, Z., & Falsafi, T. (2004). Anti-Helicobacter pylori active of six Iranian plants. Helicobacter, 9(2), 146-151. (Pubitemid 38506597)
24. Naz, S., Siddiqi, R., Ahmad, S., Rasool, S., & Sayeed, S. (2007). Antibacterial activity directed isolation of compounds from Punica granatum. Journal of Food Sciences, 72, 341-345.
25. NCCLS (1998). Methods for antimicrobial susceptibility testing for bacteria that grow aerobically. Approved standard. In NCCLS document M7-A4 (4th ed.). Wayne, PA: National Committee for Clinical Laboratory Standards.
26. Ndip, R. N., Tarkang, A. E. M., Mbullah, S. M., Luma, H. N., Malongue, A., Ndip, L. M., Efange, S. M. N. (2007). In vitro anti-Helicobacter pylori activity of extracts of selected medicinal plants from North West Cameroon. Journal of Ethnopharmacology, 114, 452-457. (Pubitemid 350026230)
27. O'Gara, E. A., Hill, D. J., & Maslin, D. J. (2000). Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori. Applied and Environmental Microbiology, 66, 2269-2273. (Pubitemid 30253767)
28. Ohsaki, A., Takashima, J., Chiba, N., & Kawamura, M. (1999). Microanalysis of a selective potent in vitro anti-Helicobacter pylori compound in a Brazilian medicinal plant, Myroxylon peruiferum and activity of the analogues. Bioorganic Medicinal Chemistry Letters, 9, 1109-1112. (Pubitemid 29204666)
29. Pritchard, D. M., & Crabtree, J. E. (2006). Helicobacter pylori and gastric cancer. Current Opinion Gastroenterology, 22, 620-625. (Pubitemid 44624528)
30. Reddy, M., Gupta, S., Jacob, M., Khan, S., & Ferreira, D. (2007). Antioxidant, antimalarial and antimicrobial activities of tannin-rich fractions, ellagitannins and phenolic acids from Punica granatum L. Planta Medica, 73, 461-467. (Pubitemid 46917461)
31. Sherif, M., Mohran, Z., Fathy, H., Rockabrand, D. M., Rozmajzl, P. J., & Frenck, R. W. (2004). Universal high-level primary metronidazole resistance in Helicobacter pylori isolated from children in Egypt. Journal of Clinical Microbiology, 42, 4832-4834. (Pubitemid 39362416)
32. Stamatis, G., Kyriazopoulos, P., Golegou, S., Basayiannis, A., Skaltsas, S., & Skaltsa, X. H. (2003). In vitro anti-Helicobacter pylori activity of Greek herbal medicines. Journal of Ethnopharmacology, 88, 175-179. (Pubitemid 37083443)
33. Suerbaum, S., & Michetti, P. (2002). Helicobacter pylori infection. The New England Journal of Medicine, 347, 1175-1186.
34. Sugiyama, T., Imai, K., Yoshida, H., Takayama, Y., Yabana, T., Yokota, K., Yachi, A. (1991). A novel enzyme immunoassay for serodiagnosis of Helicobacter pylori infection. Gastroenterology, 101, 77-83.
35. Voravuthikunchai, S. P., & Mitchell, H. (2008). Inhibitory and killing activities of medicinal plants against multiple antibiotic-resistant Helicobacter pylori. Journal of Health Science, 54(1), 81-88. (Pubitemid 351757445)
36. Wang, Y. C., & Huang, T. L. (2005). Screening of anti-Helicobacter pylori herbs deriving from Taiwanese folk medicinal plants. FEMS Immunology Medical Microbiology, 43, 295-300.
37. Zaidi, S. F., Yamada, K., Kadowaki, M., Usmanghani, K., & Sugiyama, T. (2009). Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pylori. Journal of Ethnopharmacology, 121(2), 286-291.